Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 16 | 2018 | 766 | 1.770 |
Why?
|
| Sleep Stages | 7 | 2018 | 47 | 1.360 |
Why?
|
| Sleep | 14 | 2018 | 461 | 1.300 |
Why?
|
| Polysomnography | 14 | 2012 | 151 | 0.890 |
Why?
|
| Arousal | 6 | 2008 | 171 | 0.820 |
Why?
|
| Circadian Rhythm | 10 | 2015 | 308 | 0.700 |
Why?
|
| Sleep Deprivation | 7 | 2015 | 138 | 0.650 |
Why?
|
| Wakefulness | 9 | 2012 | 136 | 0.570 |
Why?
|
| Nicotine | 1 | 2018 | 204 | 0.540 |
Why?
|
| Hydrocortisone | 7 | 2015 | 304 | 0.500 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 593 | 0.440 |
Why?
|
| Brain Waves | 1 | 2012 | 32 | 0.390 |
Why?
|
| Heart Rate | 3 | 2020 | 502 | 0.360 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 221 | 0.360 |
Why?
|
| Automation | 1 | 2011 | 112 | 0.340 |
Why?
|
| Activity Cycles | 2 | 2000 | 19 | 0.320 |
Why?
|
| Sleep, REM | 5 | 2012 | 51 | 0.320 |
Why?
|
| Trypanosomiasis, African | 5 | 2008 | 6 | 0.290 |
Why?
|
| Holidays | 2 | 2003 | 4 | 0.250 |
Why?
|
| Islam | 2 | 2003 | 34 | 0.230 |
Why?
|
| Fasting | 2 | 2003 | 167 | 0.230 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 217 | 0.210 |
Why?
|
| Adult | 24 | 2018 | 27494 | 0.210 |
Why?
|
| Delta Rhythm | 3 | 2004 | 19 | 0.210 |
Why?
|
| Hypothalamus | 2 | 2008 | 79 | 0.200 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2020 | 52 | 0.190 |
Why?
|
| Adrenal Glands | 1 | 2001 | 77 | 0.180 |
Why?
|
| Pituitary Gland | 1 | 2001 | 118 | 0.180 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2012 | 203 | 0.170 |
Why?
|
| Rest | 1 | 2020 | 51 | 0.170 |
Why?
|
| Prediabetic State | 1 | 2020 | 38 | 0.170 |
Why?
|
| Male | 23 | 2020 | 43858 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 2 | 2012 | 136 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2018 | 152 | 0.150 |
Why?
|
| Humans | 30 | 2020 | 92175 | 0.130 |
Why?
|
| Electromyography | 5 | 2011 | 191 | 0.130 |
Why?
|
| Trypanosoma brucei gambiense | 2 | 2008 | 2 | 0.130 |
Why?
|
| Parathyroid Hormone | 2 | 1997 | 221 | 0.130 |
Why?
|
| Cognition | 1 | 2000 | 594 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 68 | 0.120 |
Why?
|
| Time Factors | 8 | 2015 | 5426 | 0.120 |
Why?
|
| Electrooculography | 3 | 2011 | 21 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 741 | 0.110 |
Why?
|
| Electrocardiography | 4 | 2012 | 507 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 120 | 0.100 |
Why?
|
| Artifacts | 3 | 2011 | 246 | 0.100 |
Why?
|
| Female | 13 | 2020 | 47822 | 0.100 |
Why?
|
| Motivation | 1 | 2014 | 308 | 0.090 |
Why?
|
| Young Adult | 3 | 2018 | 6615 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 105 | 0.080 |
Why?
|
| Human Growth Hormone | 3 | 2015 | 54 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 377 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 207 | 0.080 |
Why?
|
| Narcolepsy | 1 | 2008 | 9 | 0.070 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2008 | 13 | 0.070 |
Why?
|
| Melatonin | 3 | 2012 | 51 | 0.070 |
Why?
|
| Obesity | 2 | 2014 | 1015 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2008 | 113 | 0.070 |
Why?
|
| Acetamides | 1 | 2007 | 27 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 388 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 171 | 0.060 |
Why?
|
| Body Temperature | 2 | 2003 | 127 | 0.060 |
Why?
|
| Oscillometry | 1 | 2004 | 25 | 0.060 |
Why?
|
| Patient Compliance | 2 | 2020 | 235 | 0.060 |
Why?
|
| Chronobiology Disorders | 1 | 2004 | 4 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1948 | 0.050 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2003 | 10 | 0.050 |
Why?
|
| Reference Values | 2 | 2008 | 659 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2003 | 44 | 0.050 |
Why?
|
| Facial Muscles | 1 | 2001 | 23 | 0.050 |
Why?
|
| Dextroamphetamine | 1 | 2003 | 108 | 0.050 |
Why?
|
| Darkness | 1 | 2001 | 49 | 0.050 |
Why?
|
| Aldosterone | 1 | 2001 | 56 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 50 | 0.040 |
Why?
|
| Insulin Resistance | 2 | 2015 | 377 | 0.040 |
Why?
|
| Fixation, Ocular | 1 | 2000 | 50 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 221 | 0.040 |
Why?
|
| Alpha Rhythm | 1 | 2000 | 26 | 0.040 |
Why?
|
| Homeostasis | 2 | 2003 | 450 | 0.040 |
Why?
|
| Biological Clocks | 1 | 2000 | 75 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2000 | 130 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2000 | 119 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 267 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 800 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2015 | 855 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 1998 | 52 | 0.040 |
Why?
|
| Beta Rhythm | 1 | 1998 | 19 | 0.040 |
Why?
|
| Adolescent | 5 | 2015 | 9493 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2003 | 402 | 0.040 |
Why?
|
| Time | 1 | 1998 | 79 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 1998 | 64 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1998 | 81 | 0.040 |
Why?
|
| Insulin | 2 | 2015 | 1166 | 0.040 |
Why?
|
| Autonomic Nervous System | 2 | 2010 | 66 | 0.040 |
Why?
|
| Middle Aged | 6 | 2020 | 27001 | 0.030 |
Why?
|
| Physical Endurance | 1 | 1997 | 10 | 0.030 |
Why?
|
| Thyrotropin | 1 | 1998 | 302 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1997 | 75 | 0.030 |
Why?
|
| Phosphates | 1 | 1996 | 162 | 0.030 |
Why?
|
| Calcium | 2 | 1997 | 1182 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 173 | 0.030 |
Why?
|
| Food, Organic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 327 | 0.030 |
Why?
|
| Appetite | 1 | 2014 | 26 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 146 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2014 | 31 | 0.030 |
Why?
|
| Food Preferences | 1 | 2014 | 27 | 0.030 |
Why?
|
| Vegetables | 1 | 2014 | 47 | 0.030 |
Why?
|
| Actigraphy | 1 | 2014 | 60 | 0.030 |
Why?
|
| Energy Intake | 1 | 2014 | 99 | 0.030 |
Why?
|
| Fruit | 1 | 2014 | 78 | 0.030 |
Why?
|
| Exercise | 1 | 1997 | 332 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 162 | 0.030 |
Why?
|
| Lighting | 1 | 2012 | 33 | 0.020 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 59 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 731 | 0.020 |
Why?
|
| Biomarkers | 2 | 2015 | 1846 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2008 | 9675 | 0.020 |
Why?
|
| Renin | 2 | 2001 | 67 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 1997 | 773 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 140 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 328 | 0.020 |
Why?
|
| Hematocrit | 2 | 2001 | 69 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 428 | 0.020 |
Why?
|
| Angola | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cataplexy | 1 | 2008 | 1 | 0.020 |
Why?
|
| Orexins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2008 | 151 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 124 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 234 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2007 | 128 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 756 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 950 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 305 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 313 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2004 | 2728 | 0.020 |
Why?
|
| Melarsoprol | 1 | 2005 | 1 | 0.010 |
Why?
|
| Trypanocidal Agents | 1 | 2005 | 2 | 0.010 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2004 | 4 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 75 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5697 | 0.010 |
Why?
|
| Financing, Government | 1 | 2003 | 24 | 0.010 |
Why?
|
| Rectum | 1 | 2003 | 149 | 0.010 |
Why?
|
| Child | 2 | 2005 | 7323 | 0.010 |
Why?
|
| Movement | 1 | 2004 | 318 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2003 | 121 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2003 | 156 | 0.010 |
Why?
|
| Animals | 3 | 2008 | 27974 | 0.010 |
Why?
|
| Diuresis | 1 | 2001 | 26 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 472 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1232 | 0.010 |
Why?
|
| Prolactin | 1 | 2001 | 89 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2001 | 131 | 0.010 |
Why?
|
| Affect | 1 | 2003 | 390 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3768 | 0.010 |
Why?
|
| Potassium | 1 | 2001 | 261 | 0.010 |
Why?
|
| Sodium | 1 | 2001 | 335 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 2001 | 121 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 900 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1751 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 4063 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 1997 | 66 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 34 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 270 | 0.010 |
Why?
|
| Phosphorus | 1 | 1997 | 117 | 0.010 |
Why?
|
| Veins | 1 | 1997 | 96 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 501 | 0.010 |
Why?
|
| Kidney | 1 | 2001 | 1145 | 0.010 |
Why?
|
| Bone Density | 1 | 1997 | 225 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 19915 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1997 | 308 | 0.010 |
Why?
|